Once-daily dose regimen of ribavirin is interchangeable with a twice-daily dose regimen: randomized open clinical trial

BACKGROUND: The combination of ribavirin (RBV) and pegylated interferon (PEG-IFN) is effective in the treatment of chronic hepatitis C infection. Reducing the frequency of RBV intake from twice to once a day will improve compliance and opens up the opportunity to combine RBV with new and more specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Balk, Jiska M, Haenen, Guido RMM, Koc, Özgür M, Peters, Ron, Bast, Aalt, van der Vijgh, Wim JF, Koek, Ger H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593207/
https://www.ncbi.nlm.nih.gov/pubmed/26445557
http://dx.doi.org/10.2147/PGPM.S82782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593207/
https://www.ncbi.nlm.nih.gov/pubmed/26445557
http://dx.doi.org/10.2147/PGPM.S82782

Ejemplares similares